Hematopoietic Recovery and Transfusion Support
Parameter . | PBSC . | PBSC/Split Group B . | Group A v Group B . | CD34+ Group C . | CD34+/Split Group D . | Group C v Group D P Value . | Comparison of all . |
---|---|---|---|---|---|---|---|
. | Group A . | (n = 26) . | P Value3-152 . | (n = 29) . | (n = 11) . | . | Four Groups . |
. | (n = 22) . | . | . | . | . | . | P Value . |
Days to AGC ≥500/μL | 10 (8-11)3-150 | 8 (7-11) | .0003 | 12 (8-22) | 11 (9-13) | .14 | .0001 (C,D > A > B) |
Days to platelet independence | 12 (8-24) | 11.5 (5-21) | .61 | 15 (6-22†) | 14 (12-23) | .85 | .0007 (C,D > A,B) |
No. of RBC transfusions | 4 (3-7) | 4 (2-11) | .84 | 6 (3-11) | 4 (3-14) | .45 | .008 (C > A,B) |
No. of platelet transfusions | 7.5 (3-33) | 6 (2-52) | .50 | 9 (2-26) | 9 (6-22) | .81 | .33 |
Parameter . | PBSC . | PBSC/Split Group B . | Group A v Group B . | CD34+ Group C . | CD34+/Split Group D . | Group C v Group D P Value . | Comparison of all . |
---|---|---|---|---|---|---|---|
. | Group A . | (n = 26) . | P Value3-152 . | (n = 29) . | (n = 11) . | . | Four Groups . |
. | (n = 22) . | . | . | . | . | . | P Value . |
Days to AGC ≥500/μL | 10 (8-11)3-150 | 8 (7-11) | .0003 | 12 (8-22) | 11 (9-13) | .14 | .0001 (C,D > A > B) |
Days to platelet independence | 12 (8-24) | 11.5 (5-21) | .61 | 15 (6-22†) | 14 (12-23) | .85 | .0007 (C,D > A,B) |
No. of RBC transfusions | 4 (3-7) | 4 (2-11) | .84 | 6 (3-11) | 4 (3-14) | .45 | .008 (C > A,B) |
No. of platelet transfusions | 7.5 (3-33) | 6 (2-52) | .50 | 9 (2-26) | 9 (6-22) | .81 | .33 |